These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34316657)

  • 21. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results.
    Fernandez HH; Standaert DG; Hauser RA; Lang AE; Fung VS; Klostermann F; Lew MF; Odin P; Steiger M; Yakupov EZ; Chouinard S; Suchowersky O; Dubow J; Hall CM; Chatamra K; Robieson WZ; Benesh JA; Espay AJ
    Mov Disord; 2015 Apr; 30(4):500-9. PubMed ID: 25545465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phytobezoar and duodenal ulcer as complication of Duodopa therapy in a patient affected by Parkinson's disease.
    Cerrone P; Marchese M; Pistoia MA; Marini C
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29960957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of laparoscopic jejunostomy tube to percutaneous endoscopic gastrostomy tube with jejunal extension: long-term durability and nutritional outcomes.
    Haskins IN; Strong AT; Baginsky M; Sharma G; Karafa M; Ponsky JL; Rodriguez JH; Kroh MD
    Surg Endosc; 2018 May; 32(5):2496-2504. PubMed ID: 29218657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous Endoscopic Gastrostomy with Jejunal Extension Tube for the Delivery of Levodopa Carbidopa Intestinal Gel: Clinical Practice Guidelines of the Romanian Society of Digestive Endoscopy.
    Gheorghe C; Dumitru E; Ciocîrlan M; Dobru D; Drug V; Goldis A; Jinga M; Manuc M; Saftoiu A; Seicean A; Cotruta B; Bancila I; Pitigoi D; Mercea VA; Tanțău M
    J Gastrointestin Liver Dis; 2019 Sep; 28(3):349-354. PubMed ID: 31517319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placement of the AbbVie PEG-J tube for the treatment of Parkinson's disease in the interventional radiology suite.
    Montgomery ML; Miner NK; Soileau MJ; McDonald DK
    Proc (Bayl Univ Med Cent); 2016 Oct; 29(4):420-422. PubMed ID: 27695184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
    Fernandez HH; Boyd JT; Fung VSC; Lew MF; Rodriguez RL; Slevin JT; Standaert DG; Zadikoff C; Vanagunas AD; Chatamra K; Eaton S; Facheris MF; Hall C; Robieson WZ; Benesh J; Espay AJ
    Mov Disord; 2018 Jul; 33(6):928-936. PubMed ID: 29570853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic management of duodenal levodopa-carbidopa therapy of advanced Parkinson's disease.
    Garrido Durán C; Khorrami Minaei S; Sendra Rumbeu P; Fernández García J; García Hernández M; Legarda Ramírez I
    Rev Esp Enferm Dig; 2019 Nov; 111(11):828-832. PubMed ID: 31566412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: interim results.
    Fernandez HH; Vanagunas A; Odin P; Espay AJ; Hauser RA; Standaert DG; Chatamra K; Benesh J; Pritchett Y; Hass SL; Lenz RA
    Parkinsonism Relat Disord; 2013 Mar; 19(3):339-45. PubMed ID: 23287001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of complication rates, types, and average tube patency between jejunostomy tubes and percutaneous gastrostomy tubes in a regional home enteral nutrition support program.
    Ao P; Sebastianski M; Selvarajah V; Gramlich L
    Nutr Clin Pract; 2015 Jun; 30(3):393-7. PubMed ID: 25378355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease.
    Epstein M; Johnson DA; Hawes R; Schmulewitz N; Vanagunas AD; Gossen ER; Robieson WZ; Eaton S; Dubow J; Chatamra K; Benesh J
    Clin Transl Gastroenterol; 2016 Mar; 7(3):e159. PubMed ID: 27030949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic suturing for the management of recurrent dislodgment of percutaneous endoscopic gastrostomy-jejunostomy tube.
    Agnihotri A; Barola S; Hill C; Mishra P; Fayad L; Dunlap M; Moran RA; Singh VK; Kalloo AN; Khashab MA; Kumbhari V
    J Dig Dis; 2018 Mar; 19(3):170-176. PubMed ID: 29389058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application of levodopa/carbidopa intestinal gel in advanced Parkinson's disease].
    Toth A; Nagy H; Wacha J; Bereczki D; Takáts A
    Neuropsychopharmacol Hung; 2015 Dec; 17(4):191-6. PubMed ID: 26727723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Real-time 3D reconstruction CT-jejunography guided direct percutaneous endoscopic jejunostomy for levodopa-carbidopa intestinal gel treatment in a patient with prior gastrojejunostomy].
    Tomiyasu K; Oshima T; Yoshii M; Ichikawa T; Inamasu J; Kimata M
    Rinsho Shinkeigaku; 2022 Apr; 62(4):298-300. PubMed ID: 35354726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoscopic Complications Are More Frequent in Levodopa-Carbidopa Intestinal Gel Treatment via JET-PEG in Parkinson's Disease Patients Compared to Nutritional PEG in Non-Parkinson's Disease Patients.
    Gombošová L; Deptová J; Jochmanová I; Svoreňová T; Veseliny E; Zakuciová M; Haň V; Lacková A; Kulcsárová K; Ostrožovičová M; Ventosa JR; Trcková L; Lazúrová I; Škorvánek M
    J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337398
    [No Abstract]   [Full Text] [Related]  

  • 35. Using tube feeding and levodopa-carbidopa intestinal gel application in advanced Parkinson's disease.
    Lex KM; Kundt FS; Lorenzl S
    Br J Nurs; 2018 Mar; 27(5):259-262. PubMed ID: 29517331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent experience with percutaneous endoscopic gastrostomy/jejunostomy (PEG/J) for enteral nutrition.
    Simon T; Fink AS
    Surg Endosc; 2000 May; 14(5):436-8. PubMed ID: 10858466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CT fluoroscopy guided percutaneous gastrostomy or jejunostomy without (CT-PG/PJ) or with simultaneous endoscopy (CT-PEG/PEJ) in otherwise untreatable patients.
    Spelsberg FW; Hoffmann RT; Lang RA; Winter H; Weidenhagen R; Reiser M; Jauch KW; Trumm C
    Surg Endosc; 2013 Apr; 27(4):1186-95. PubMed ID: 23232989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Intestinal Bacteria on Levodopa Pharmacokinetics in LCIG Therapy.
    Yamanishi Y; Choudhury ME; Yoshida A; Hosokawa Y; Miyaue N; Tada S; Ando R; Murakami S; Miyamoto H; Nagai M
    Mov Disord Clin Pract; 2022 Apr; 9(3):362-368. PubMed ID: 35402640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.
    Olanow CW; Kieburtz K; Odin P; Espay AJ; Standaert DG; Fernandez HH; Vanagunas A; Othman AA; Widnell KL; Robieson WZ; Pritchett Y; Chatamra K; Benesh J; Lenz RA; Antonini A;
    Lancet Neurol; 2014 Feb; 13(2):141-9. PubMed ID: 24361112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a retrospective study.
    Simoni S; Nigro P; Filidei M; Cappelletti G; Paolini Paoletti F; Castellani D; Gaggiotti M; Parnetti L; Tambasco N
    BMC Neurol; 2022 Jan; 22(1):25. PubMed ID: 35026993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.